Aslan Pharma ADR earnings miss, Revenue Inline in Q1
Investing.com - Aslan Pharma ADR reported on Wednesday first quarter {{erl-1073897||earnings that missed analysts' forecasts and revenue that was inline with expectations. Aslan Pharma ADR...
Neutral
or
Aslan Pharma ADR News & Analysis
-
-
Aslan Pharma ADR earnings miss, Revenue Inline in Q1
Investing.com - Aslan Pharma ADR reported on Friday first quarter {{erl-1073897||earnings that missed analysts' forecasts and revenue that was inline with expectations. Aslan Pharma ADR...
-
ASLAN Pharmaceuticals Announces Acceptance of Late-Breaking Abstract on Eblasakimab Proof-of-Concept Study in Atopic Dermatitis for Oral Presentation at the 2022 American Academy of Dermatology Annual Meeting
- Topline data from the eblasakimab Phase 1b multiple-ascending-dose study will be presented during the "Late-breaking Research: Clinical Trials" session at the 2022 American Academy of...
-
Aslan Pharma ADR earnings beat, Revenue Inline in Q3
Investing.com - Aslan Pharma ADR reported on Tuesday third quarter {{erl-1073897||earnings that beat analysts' forecasts and revenue that was inline with expectations. Aslan Pharma ADR...
-
Aslan Pharma ADR earnings beat, Revenue Inline in Q2
Investing.com - Aslan Pharma ADR reported on Friday second quarter {{erl-1073897||earnings that beat analysts' forecasts and revenue that was inline with expectations. Aslan Pharma ADR...
-
Aslan Pharma ADR earnings miss, Revenue Inline in Q1
Investing.com - Aslan Pharma ADR reported on Tuesday first quarter {{erl-1073897||earnings that missed analysts' forecasts and revenue that was inline with expectations. Aslan Pharma ADR...
-
Aslan Pharma ADR earnings miss, Revenue Inline in Q1
Investing.com - Aslan Pharma ADR reported on Thursday first quarter {{erl-1073897||earnings that missed analysts' forecasts and revenue that was inline with expectations. Aslan Pharma ADR...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 1.01%
Investing.com – U.S. equities were lower at the close on Tuesday, as losses in the Oil & Gas, Basic Materials and Consumer Services sectors propelled shares lower. At the close in NYSE, the...
-
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.15%
Investing.com – U.S. equities were higher at the close on Wednesday, as gains in the Consumer Services, Telecoms and Healthcare sectors propelled shares higher. At the close in NYSE, the...
-
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.39%
Investing.com – U.S. equities were higher at the close on Friday, as gains in the Consumer Services, Financials and Telecoms sectors propelled shares higher. At the close in NYSE, the Dow...
-
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.04%
Investing.com – U.S. equities were mixed at the close on Monday, as gains in the Industrials, Telecoms and Financials sectors propelled shares higher while losses in the Utilities, Oil & Gas...
-
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.09%
Investing.com – U.S. equities were mixed at the close on Thursday, as gains in the Technology, Industrials and Oil & Gas sectors propelled shares higher while losses in the Telecoms,...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
